Vicarious Surgical Inc. (RBOT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Vicarious Surgical Statistics
Share Statistics
Vicarious Surgical has 5.91M shares outstanding. The number of shares has increased by -96.64% in one year.
Shares Outstanding | 5.91M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.19% |
Owned by Institutions (%) | n/a |
Shares Floating | 3.05M |
Failed to Deliver (FTD) Shares | 17 |
FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 65.84K, so 1.11% of the outstanding shares have been sold short.
Short Interest | 65.84K |
Short % of Shares Out | 1.11% |
Short % of Float | 2.16% |
Short Ratio (days to cover) | 3.49 |
Valuation Ratios
The PE ratio is -0.75 and the forward PE ratio is -1.25.
PE Ratio | -0.75 |
Forward PE | -1.25 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 0.54 |
P/FCF Ratio | -0.83 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vicarious Surgical Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.87, with a Debt / Equity ratio of 0.15.
Current Ratio | 13.87 |
Quick Ratio | 13.87 |
Debt / Equity | 0.15 |
Total Debt / Capitalization | 13.15 |
Cash Flow / Debt | -4.2 |
Interest Coverage | -3226.64 |
Financial Efficiency
Return on equity (ROE) is -0.73% and return on capital (ROIC) is -71.51%.
Return on Equity (ROE) | -0.73% |
Return on Assets (ROA) | -0.59% |
Return on Capital (ROIC) | -71.51% |
Revenue Per Employee | 0 |
Profits Per Employee | -550.94K |
Employee Count | 129 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 17.01% in the last 52 weeks. The beta is 1.03, so Vicarious Surgical 's price volatility has been higher than the market average.
Beta | 1.03 |
52-Week Price Change | 17.01% |
50-Day Moving Average | 13.19 |
200-Day Moving Average | 9.06 |
Relative Strength Index (RSI) | 52.98 |
Average Volume (20 Days) | 44.12K |
Income Statement
Revenue | n/a |
Gross Profit | -1.85M |
Operating Income | -80.67M |
Net Income | -71.07M |
EBITDA | -69.19M |
EBIT | n/a |
Earnings Per Share (EPS) | -14.7 |
Balance Sheet
The company has 52.82M in cash and 14.83M in debt, giving a net cash position of 37.99M.
Cash & Cash Equivalents | 52.82M |
Total Debt | 14.83M |
Net Cash | 37.99M |
Retained Earnings | -132.71M |
Total Assets | 80.62M |
Working Capital | 55.37M |
Cash Flow
In the last 12 months, operating cash flow was -62.30M and capital expenditures -1.67M, giving a free cash flow of -63.98M.
Operating Cash Flow | -62.30M |
Capital Expenditures | -1.67M |
Free Cash Flow | -63.98M |
FCF Per Share | -13.23 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RBOT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -102.23% |
FCF Yield | -75.27% |
Analyst Forecast
The average price target for RBOT is $10.25, which is -28.7% lower than the current price. The consensus rating is "Hold".
Price Target | $10.25 |
Price Target Difference | -28.7% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Stock Splits
The last stock split was on Jun 13, 2024. It was a backward split with a ratio of 1:30.
Last Split Date | Jun 13, 2024 |
Split Type | backward |
Split Ratio | 1:30 |
Scores
Altman Z-Score | -2.62 |
Piotroski F-Score | 3 |